| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Surzebiclimab | Surzebiclimab | 2342597-90-2 |
| Fremanezumab | 瑞玛奈珠单抗 | 1655501-53-3 |
| Eptinezumab | 依普奈珠单抗 | 1644539-04-7 |
| Emicizumab | Emicizumab | 1610943-06-0 |
| Durvalumab | 德瓦鲁单抗 | 1428935-60-7 |
| Aducanumab | 阿杜那单抗 | 1384260-65-4 |
| Obiltoxaximab | Obiltoxaximab | 1351337-07-9 |
| Secukinumab | 苏金单抗 | 1229022-83-6 |
| (3aR,9bS)-6,8-difluoro-4-(pyridin-3-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline | (3aR,9bS)-6,8-difluoro-4-(pyridin-3-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline | 1005036-73-6 |
| afelimomab | 阿非莫单抗 | 156227-98-4 |
| acyloxyacyl hydrolase | acyloxyacyl hydrolase | 110277-64-0 |
| Agalsidase Beta | AGALSIDASE BETA | 104138-64-9 |
| Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer | 那他珠单抗 | 189261-10-7 |
| Evolocumab | 依洛尤单抗 | 1256937-27-5 |
| Vedolizumab | 维多珠单抗 | 943609-66-3 |
| TocilizuMab | 托珠单抗 | 375823-41-9 |
| Dulaglutide | 杜拉鲁肽 | 923950-08-7 |
| Avelumab | 阿维鲁单抗 | 1537032-82-8 |
| Lirilumab | Lirilumab | 1000676-41-4 |
| varlilumab | 伐立鲁单抗 | 1393344-72-3 |
